Autologous Myoblast Transplantation for Oculopharyngeal Muscular Dystrophy: a Phase I/Iia Clinical Study-Reference-Cited by-同舟云学术

Autologous Myoblast Transplantation for Oculopharyngeal Muscular Dystrophy: a Phase I/Iia Clinical Study

Published:2014-01 Issue:1 Volume:22 Page:219-225
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Périé Sophie,Trollet Capucine,Mouly Vincent,Vanneaux Valérie,Mamchaoui Kamel,Bouazza Belaïd,Marolleau Jean Pierre,Laforêt Pascal,Chapon Françoise,Eymard Bruno,Butler-Browne Gillian,Larghero Jérome,St Guily Jean Lacau

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference30 articles.

1. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy;Brais;Nat Genet,1998

2. Oropharyngeal dysphagia in patients with oculopharyngeal muscular dystrophy;Duranceau;Can J Surg,1978

3. Dysphagia in oculopharyngeal myopathies. Report of 7 cases;Lacau St Guily;Ann Otolaryngol Chir Cervicofac,1990

4. Dysphagia in oculopharyngeal muscular dystrophy: a series of 22 French cases;Périé;Neuromuscul Disord,1997

5. Surgery in oculopharyngeal muscular dystrophy;Duranceau;Am J Surg,1980

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and established biomarkers of oculopharyngeal muscular dystrophy;Neuromuscular Disorders;2023-11

2. Bioprocessing Considerations towards the Manufacturing of Therapeutic Skeletal and Smooth Muscle Cells;Bioengineering;2023-09-09

3. Potency assays and biomarkers for cell-based advanced therapy medicinal products;Frontiers in Immunology;2023-06-09

4. Mesoangioblasts at 20: From the embryonic aorta to the patient bed;Frontiers in Genetics;2023-01-04

5. Clinical Trials of Cell Therapy and Regenerative Medicine in Muscular Dystrophies;Handbook of Stem Cell Applications;2023